NCT07125755View on ClinicalTrials.gov

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

August 15, 2028

Study Completion Date

August 15, 2031

Conditions
Squamous Cell Cancer of Head and Neck (SCCHN)
Interventions
DRUG

Cisplatin

Concurrent Cisplatin chemotherapy (100 mg/m2 intravenous injection,once every 3 weeks, twice in total, on days 1 and 22) will be given plus intensity modulated radiotherapy

Trial Locations (7)

523000

Sun Yat-sen University Cancer Center, Guangzhou

Sun Yat-sen University Cancer Center, Guangzhou

Unknown

Affiliated Hospital of Guilin Medical College, Guilin

Hainan General Hospital, Sanya

Hunan Cancer Hospital, Changsha

Xiangya Hospital, Central South University, Changsha

Jiangsu Cancer Hospital, Nanjing

All Listed Sponsors
lead

Sun Yat-sen University

OTHER